EGFR and skin disorder: The clinical use of polydatin in skin disorders is also supported by the evidence that interleukin-8 (IL-8) plays a key role in inducing cutaneous AEs associated with anti-EGFR treatment, since polydatin is known to regulate IL-8 gene expression [22,27].